meglumine antimoniate has been researched along with phenylephrine hydrochloride in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Achour, I; Chakroun, A; Charfeddine, I; Ghorbel, A; Hammami, B; Mnejja, M; Turki, H | 1 |
Confort, EM; da Costa, DC; da Silva, AF; Madeira, Mde F; Martins, AC; Moreira, JS; Palmeiro, MR; Quintella, LP; Schubach, Ade O; Silva, Fda C; Valete-Rosalino, CM | 1 |
Abbas, O; Alam, E; Khalifeh, I; Moukarbel, R | 1 |
Goyonlo, VM; Taghavi, F; Vahabi-Amlashi, S | 1 |
4 other study(ies) available for meglumine antimoniate and phenylephrine hydrochloride
Article | Year |
---|---|
Unusual form of cutaneous leishmaniasis: erysipeloid form.
Topics: Antiprotozoal Agents; Biopsy; Diagnosis, Differential; Erysipeloid; Facial Dermatoses; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Nose; Nose Diseases; Organometallic Compounds; Polymerase Chain Reaction; Skin | 2011 |
Oral manifestations in the American tegumentary leishmaniasis.
Topics: Antiprotozoal Agents; Female; Humans; Larynx; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mouth Diseases; Mouth Mucosa; Nose; Nose Diseases; Organometallic Compounds; Pharynx; Prognosis; Retrospective Studies | 2014 |
Cutaneous Leishmaniasis: An Overlooked Etiology of Midfacial Destructive Lesions.
Topics: Adolescent; Adult; Biopsy; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Nose; Nose Diseases; Organometallic Compounds; Polymerase Chain Reaction; Young Adult | 2016 |
Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis.
Topics: Antiprotozoal Agents; Humans; Iran; Leishmania tropica; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Nose; Thalidomide; Young Adult | 2019 |